SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $18,490,000 | +11.5% | 1,650,696 | +9.5% | 0.00% | +100.0% |
| Q2 2017 | $16,590,000 | +7.6% | 1,508,053 | -4.1% | 0.00% | 0.0% |
| Q1 2017 | $15,423,000 | -0.4% | 1,573,265 | +9.8% | 0.00% | 0.0% |
| Q4 2016 | $15,482,000 | +3.9% | 1,433,388 | -1.4% | 0.00% | -50.0% |
| Q3 2016 | $14,901,000 | -9.0% | 1,454,110 | +16.0% | 0.00% | 0.0% |
| Q2 2016 | $16,373,000 | +50.7% | 1,253,599 | +27.0% | 0.00% | +100.0% |
| Q1 2016 | $10,864,000 | +9.8% | 987,384 | -8.2% | 0.00% | 0.0% |
| Q4 2015 | $9,892,000 | -29.0% | 1,075,097 | -46.4% | 0.00% | -50.0% |
| Q3 2015 | $13,926,000 | -23.3% | 2,006,869 | +8.6% | 0.00% | 0.0% |
| Q2 2015 | $18,148,000 | +120.9% | 1,848,037 | +99.4% | 0.00% | +100.0% |
| Q1 2015 | $8,214,000 | +3.0% | 926,885 | +1.9% | 0.00% | 0.0% |
| Q4 2014 | $7,974,000 | +13.9% | 909,608 | -10.5% | 0.00% | 0.0% |
| Q3 2014 | $7,003,000 | +36.3% | 1,016,218 | +4.1% | 0.00% | 0.0% |
| Q2 2014 | $5,137,000 | +13.6% | 975,775 | -1.8% | 0.00% | 0.0% |
| Q1 2014 | $4,522,000 | -53.2% | 993,597 | -52.1% | 0.00% | 0.0% |
| Q4 2013 | $9,661,000 | +85.5% | 2,072,863 | +102.0% | 0.00% | 0.0% |
| Q3 2013 | $5,207,000 | +1.3% | 1,026,364 | -0.9% | 0.00% | 0.0% |
| Q2 2013 | $5,138,000 | – | 1,036,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|